Vertex Pharmaceuticals Inc 10-K for FY2025
Vertex Pharmaceuticals Inc (VRTX)
10-K
2026-02-13
For: 2025-12-31
View Original
Added on
April 02, 2026
About this 10-K
Vertex Pharmaceuticals Inc filed this 10-K on February 13, 2026, covering the fiscal year ended December 31, 2025 (FY2025).
Headline figures
Fiscal year ended December 31, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $12B
- up 8.9% from $11.02B a year earlier
- Net income
- $3.95B
- compared with a net loss of $535.6M a year earlier
- Diluted EPS
- $15.32
- compared with -$2.08 a year earlier